MedTrace Logo

Enhancing Scleral Lens Fit With Advanced Imaging

NCT06751615 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-12-30

No results posted yet for this study

Summary

The goal of this experimental clinical trial is to enhance the predictability and precision of scleral lens fitting in patients with complex corneal conditions such as keratoconus, post-surgical irregularities, and severe dry eye syndrome. The main questions it aims to answer are:

Can detailed sagittal height measurements obtained from the Oculus Pentacam Corneal Scleral Profile (CSP) predict the necessary adjustments for optimal scleral lens fit? Will the use of these measurements reduce the number of trial-and-error adjustments needed to achieve an ideal fit, thereby reducing chair time and improving patient satisfaction?

Participants will:

Undergo detailed corneal and scleral tomography using the Oculus Pentacam with the CSP strategy.

Receive customized ICD 16.5 mm scleral lenses based on precise measurements of their ocular surface.

Participate in follow-up assessments to evaluate the fit of the lenses and provide feedback on comfort and visual outcomes.

This study focuses on a specific participant population of adults aged 18 and older who have not had success with other types of contact lenses. By leveraging advanced imaging technologies, the research aims to streamline the fitting process for scleral lenses, potentially setting new standards for treatment efficacy in specialty contact lens practices.

Conditions

  • Keratoconus
  • Astigmatism High

Sponsors & Collaborators

  • Centro de Miopía Fernández-Velázquez

    collaborator NETWORK

  • Fernando Fernandez Velazquez

    lead NETWORK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06751615 on ClinicalTrials.gov